| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| HYZAAR DS | 25MG 100MG | TABLET | Resolved | 2019-11-21 | 2019-12-14 | 99496 |
| HYZAAR DS | 25MG 100MG | TABLET | Resolved | 2020-02-21 | 2020-03-03 | 106834 |
| INHIBACE PLUS | 5MG 12.5MG | TABLET | Resolved | 2021-01-04 | 2021-10-19 | 130792 |
| INHIBACE PLUS | 12.5MG 5MG | TABLET | Resolved | 2024-06-17 | 2024-10-19 | 230712 |
| INHIBACE PLUS | 12.5MG 5MG | TABLET | Resolved | 2022-08-17 | 2022-09-30 | 166884 |
| INHIBACE PLUS | 12.5MG 5MG | TABLET | Resolved | 2022-05-09 | 2022-05-25 | 160204 |
| IRBESARTAN HCT | 300MG 12.5MG | TABLET | Resolved | 2020-10-16 | 2021-02-12 | 126603 |
| IRBESARTAN HCT | 12.5MG 300MG | TABLET | Resolved | 2018-11-12 | 2018-12-29 | 66698 |
| IRBESARTAN HCT | 150MG 12.5MG | TABLET | Resolved | 2020-10-16 | 2021-02-12 | 126600 |
| IRBESARTAN HCT | 12.5MG 150MG | TABLET | Resolved | 2019-04-01 | 2019-05-06 | 80252 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ALTACE HCT | 12.5MG 10MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214024 |
| ALTACE HCT | 25MG 10MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214027 |
| ALTACE HCT | 12.5MG 5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214014 |
| ALTACE HCT | 25MG 5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214017 |
| ALTACE HCT | 12.5MG 2.5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214011 |
| AMI-HYDRO TAB | 50MG 5MG | TABLET | Discontinued | 2017-05-08 | 2017-05-08 | 9475 |
| APO-HYDROCHLOROTHIAZIDE | Discontinued | 2019-11-26 | 2019-11-26 | 99653 | ||
| APO-HYDROCHLOROTHIAZIDE | 50MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60521 |
| APO TRIAZIDE | 50MG 25MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60837 |
| AA-AMILZIDE | 50MG 5MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60166 |